CORC  > 中国医学科学院 北京协和医学院
Glycogen synthase kinase-3 beta inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma
Zhang, Na; Liu, Xiaojia; Liu, Lu; Deng, Zhesong; Zeng, Qingxuan; Pang, Weiqiang; Liu, Yang; Song, Danqing; Deng, Hongbin
2018
卷号9期号:2页码:230
ISSN号2041-4889
DOI10.1038/s41419-018-0309-3
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6360568
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Zhang, Na,Liu, Xiaojia,Liu, Lu,et al. Glycogen synthase kinase-3 beta inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma[J],2018,9(2):230.
APA Zhang, Na.,Liu, Xiaojia.,Liu, Lu.,Deng, Zhesong.,Zeng, Qingxuan.,...&Deng, Hongbin.(2018).Glycogen synthase kinase-3 beta inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma.,9(2),230.
MLA Zhang, Na,et al."Glycogen synthase kinase-3 beta inhibition promotes lysosome-dependent degradation of c-FLIPL in hepatocellular carcinoma".9.2(2018):230.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace